HBI reports from the Sub-Saharan Africa panel at HBI 2019, where Teo Sarda, CEO of Sphera, Dr Shrey Viranna, CEO of Life, and Audrey Obara, head of healthcare for Swedfund, talked about how to sustainably invest in Africa.
Deloitte is starting to launch an array of healthcare assets, as well as acting as an adviser. Is this a move into operations management? HBI speaks to Sara Siegel, head of healthcare at Deloitte UK.
Three of the Nordic's largest operators took to the stage at HBI 2019 to speak about pan-Nordic collaboration. Here's what Fredrik Gren, CEO of Ambea, Alexander Wennergren Helm, CEO of Aleris, and Yrjö Närnhinen, CEO of Terveystalo, said.
Here are 10 more things that piqued our interest at HBI 2019, where sector stakeholders from payors to investors come together to grapple with the biggest and most interesting issues of the year.
Why did Bupa, the international health insurer which is also one of the largest health care service players outside of the USA, announce its 2018 results so quietly that HBI isn't aware of any UK daily reporting them this year? The figures show that Bupa's £3.37bn of revenue from nursing homes, hospitals, dentistry and primary care across a dozen countries, barely made money. Could this be down to its interesting governance structure?
This week delegates from around the world descended on London for HBI 2019 to discuss the healthcare market and its various sub-sectors. Here are the things we learnt:
The new(ish) CEOs of Life and Mediclinic are keen to engage beyond their traditional elite markets of around 9m people. We look at new affordable models and where they could be exported beyond the rainbow nation. Both Life's Shrey Viranna and Mediclinic's Ronnie Van Der Merwe were at HBI 2019.
Is it possible to make money in private pay primary care in South Africa by building affordable primary care clinics? We speak to the group MD of Pulse Health who is endeavouring to do just that.
Two of Europe’s biggest healthcare companies which were widely expected to IPO imminently are now, we hear, ruling out this year. Why the delay – and what does this tell us about the state of a slowing market? HBI speaks to an operator CEO and investment banking sources.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.